Biochemical and Biological Markers of Neoplastic Transformation (Nato Science Series A:, 57)

At the beginning of this conference, it is certainly worthwhile to survey our present knowledge of the possible association or linkage between human malignancies and the most powerful and polymorphic marker : the HLA system. Indeed a considerable number of studies have been carried out since the first two studies ~one in France on acute lymphoblastic leukemia 1 and HodgkLn's disease 2 . This research was rather disappointing in comparison with the rich harvest obtained by the study of many other nonmalignant diseases 3 ,4,S. It is striking that among the diseases undoubtedly associated with HLA, there are practically no infectious diseases due to a well-known agent, and no malignant diseases. However, the role of the MHC in malignancies is clearly demonstrated in animal experiments. This intervention can take place at several levels. familial Hodgkin's disease. Excess of HLA identical affected sibs, Eur. Front Matter....Pages i-xv Some Considerations on HLA and Malignancies....Pages 1-15 Monoclonal Antibodies Specifying Antigens Associated with Rat Tumors and Their Use in Drug Delivery Systems....Pages 17-27 Immunological Markers of Human Leukemic Cells of the B Lineage....Pages 29-43 Expression of Normal Differentiation Antigens on Human Leukemias and Lymphomas....Pages 45-56 Human-Human Hybridoma Monoclonal Antibodies in Diagnosis and Treatment of Neoplastic Disease....Pages 57-66 Surface Antigens on Normal and Malignant Lymphoid Cells....Pages 67-81 Immune Recognition of Tumor Cells Detected by Lymphocyte Mediated Cytotoxicity....Pages 83-95 Some Characteristics of Non-Immunoglobulin Components in Low pH Extracts of A Non-Lymphoid Tumor....Pages 97-110 Immunogenetic Determinants of Metastatic Cells....Pages 111-120 Spontaneous Phenotypic Shifts from Low to High Metastatic Capacity....Pages 121-131 Histocompatibility Antigens on the Cell Surface of Tumors....Pages 133-145 The Immunogenetics of MHC Controlled Antigenic Determinants on Lewis-Lung-Carcinoma (3LL) Cells....Pages 147-158 Genetics of Human Cancer with Special Reference to Model Cancers....Pages 159-170 Chromosome Breakage and Sensitivity to DNA Breaking Agents in Ataxia-Telangiectasia and their Possible Association with Predisposition to Cancer....Pages 171-183 Derepression and Modulation of Plasminogen Activator in Human Cell Hybrids and Their Segregants....Pages 185-192 Biochemical Markers for Human Leukemia and Cell Differentiation....Pages 193-216 Adenosine Deaminase and Terminal Transferase in Leukemic Cells....Pages 217-232 Poly (A)-Polymerase Levels in Lymphoid Cells from Acute and Chronic Lymphocytic Leukemias....Pages 233-241 Are Polyamines Useful Markers for Monitoring Cancer Therapy?....Pages 243-249 ADP-Ribosylation of Proteins in Normal and Neoplastic Tissues....Pages 251-262 Alterations in tRNA Metabolism as Markers of Neoplastic Transformation....Pages 263-275 Antibodies to Chromosomal Non-Histone Proteins in Malignant Cells....Pages 277-294 Transformation-Enhancing Factors and Fibronectin Degradation Products as Possible Tumour Markers....Pages 295-305 Affinity Modulation of Epidermal Growth Factor Membrane Receptors by Biologically Active Phorbol and Ingenol Esters....Pages 307-320 Regulation of Cytidine Uptake in Ehrlich Ascites Tumour Cells....Pages 321-328 Glucocorticoid Receptors and Sensitivity in Normal and Neoplastic Human Lymphoid Tissues....Pages 329-346 Immunocytochemical Detection of Glucocorticoid Receptors in Lymphocytes and Breast Tumor Cells....Pages 347-356 Oestrogen and Progestin Receptors as Markers for the Behaviour of Human Breast Tumours....Pages 357-370 Androgen Receptor Assay in Human Prostate Cancer....Pages 371-379 Modulation of 5-Fluorouracil Toxicity via Estrogen Receptor....Pages 381-390 T-Lymphocyte Tolerance in RNA Tumor Virus Oncogenesis: A Model for the Clonal Abortion Hypothesis....Pages 391-407 Transforming Genes of Avian Retroviruses and Their Relation to Cellular Prototypes....Pages 409-431 Nucleotide Sequence Analysis of Integrated Avian Myeloblastosis Virus (AMV) Long Terminal Repeat (LTR) and Their Host and Viral Junctions: Structural Similarities to Transposable Elements....Pages 433-443 Quantitative Changes of Some Cellular Polypeptides in C3H Mouse Cells Following Transformation by Moloney Sarcoma Virus....Pages 445-455 Tumor Antigens and Transformation-Related Proteins Associated with Feline Retroviruses....Pages 457-470 Leukemogenesis by Bovine Leukemia Virus....Pages 471-478 The Cloning and Analyses of Human Cellular Genes Homologous to Retroviral Onc Genes....Pages 479-492 Properties of an RNA Retrovirus Continuously Produced at Low Levels by a Human Histiocytic Lymphoma Cell Line....Pages 493-502 Human T-Cell Retrovirus and Adult T-Cell Lymphoma and Leukemia: Possible Factors on Viral Incidence....Pages 503-513 Reverse Transcriptase: A Molecular Probe for the Expression of Retroviral Information in Human Tumors....Pages 515-528 Clinical Trials with a Partially Thiolated Polycytidylic Acid, a Potent Inhibitor of Retroviral Reverse Transcriptase, in the Treatment of Acute Childhood Leukemia....Pages 529-535 Subcellular Localization of Simian Virus 40 T-Antigen....Pages 537-554 Involvement of Herpes Simplex Virus in Cervical Carcinoma....Pages 555-572 The Role of Epstein-Barr Virus in Burkitt’s Lymphoma....Pages 573-580 Immunological Control of EBV Infected B Cells....Pages 581-593 Papillomaviruses....Pages 595-601 Hepatitis B Virus: Molecular Biology Studies on its Presumptive Role in Human Primary Liver Cancer....Pages 603-615 Viral Markers in Human Malignancies — Epidemiological Studies....Pages 617-625 Back Matter....Pages 627-639 This volume is arecord of the proceedings of a NATO Advanced Study institute on "Biochemical and Bio- logical Markers of Neoplastic Transformation" held September 28 - October 8, 1981, at Corfu, Greece. As early as 1860, Rudolf Virchow provided the first genetic concept of cancer by postulating "Omnia ceZZuZa e ceZZuZa ejusdem generis", a modification of the then exisiting cell theory "Omnis ceZZuZa e ceZZuZa". Thus, the idea that all cells originate from the parent cell was extended to the idea that all cancer cells come from the "paren t" cancer cello But how the first cancer cell arose, or in other words, how anormal cell changed to a cancer cell, is, even after 120 years, a mystery. Experimental studies of the past have convinced us that a number of factors contribute to the neoplastic transformation of anormal cell, but our knowledge on the mechanisms involved in this process is still in an embryonic state. In the last few years, however, this field has witnessed a most remarkable advancement cata- lyzed by the development of modern technology in the al lied fields of immunology, the production of mono- clonal antibodies, molecular biology, and sequencing v PREFACE and cloning of ONC genes. Presently, it is becoming more and more evident to the wishful mind of those engaged in this research that we are approaching a turning point. Thus, an assessment of the present situa- tion will be most desirable at this time.